Share of U.S. opioid ED visits prescribed naloxone or buprenorphine 2019-2021

A study that analyzed 148,966 emergency departments (ED) visits for opioid overdose in the United States that occured between August 4, 2019 and April 3, 2021 found that in only 7.4 percent of cases were patients prescribed naloxone within 30 days of their ED visit. Naloxone is a potentially lifesaving medication that can rapidly reverse an opioid overdose. This statistic shows the share of U.S. emergency department visits for opioid overdose from August 2019 to April 2021 in which naloxone or buprenorphine were prescribed within 30 days, by region.

一项针对2019年8月4日至2021年4月3日期间美国148,966例阿片类药物过量急诊科（ED）就诊的研究发现，仅在7.4%的病例中，病人在急诊科就诊后的30天内被开具了纳洛酮处方。纳洛酮是一种可能挽救生命的药物，能够迅速逆转阿片类药物过量。此统计数据揭示了2019年8月至2021年4月美国急诊科阿片类药物过量就诊中，在30天内开具纳洛酮或丁丙诺啡的比例，按地区划分。